Marie McDonnell, MD: New Basal Insulins for Type 2 Diabetes
Marie E. McDonnell, MD, of Brigham & Women's Hospital, Boston, Massachusetts, discusses implementing effective behavior change for patients with diabetes.
The high prevalence of T2D in African American women could explain previously identified racial disparities in breast cancer incidence.
Levels of high sensitivity C-reactive protein may help risk stratify those patients with T2D and recent acute coronary syndrome at further risk of recurrent cardiovascular events.
A study of the once-weekly investigational dipeptidyl peptidase-4 omarigliptin reported a clinically meaningful reduction in glycated hemoglobin that was maintained throughout the study.